Biokin Pharmaceutical (688506.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec7

Belayidiantianhen Publishes Clinical Study Results of T-Bren (BL-M07D1)

10:48

Nov30

BMS Pays $250 Million Milestone Payment to Bailing Tianheng's Subsidiary

08:59

Nov23

Belayi Tianheng's EGFR×HER3 Dual Antibody ADC Drug Marketing Application Accepted for Review

07:45

Nov20

Bailitianheng Signs Strategic Cooperation Agreement with Bank of China Sichuan Branch

02:45

Nov18

Bailitiantian's Iza-bren Reaches Dual Primary Endpoints in Phase III Clinical Trials for Esophageal Cancer

00:26

Oct27

KlauenBiotec and BailingTianheng Showcase ADC Clinical Data at ESMO

03:42

Schedules & Filings

Schedules

Filings

Oct26

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.895 B, Net Income 623.44 M, EPS 1.5403

Aug30

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 103.76 M, Net Income -586.52 M, EPS -1.4596

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More